Literature DB >> 18836793

Elevated levels of soluble fibrin in patients with venous thromboembolism.

Akihiro Tsuji1, Hideo Wada2, Takeshi Matsumoto3, Yasunori Abe4, Satoshi Ota1, Norikazu Yamada1, Takashi Sugiyama5, Akihiro Sudo6, Katsuya Onishi7, Kaname Nakatani7, Atsumasa Uchida6, Masaaki Ito1, Koji Suzuki8, Tsutomu Nobori7.   

Abstract

The fibrin-related markers (FRMs), including soluble fibrin (SF), D-dimer and fibrin and fibrinogen degradation products (FDP) are considered to be useful for the diagnosis of thrombosis; however, evidence for the diagnosis of thrombosis by SF is still not well established. The present study was designed to evaluate the usefulness of SF in the diagnosis of venous thromboembolism (VTE). The plasma concentrations of FRMs were measured in 551 in-patients suspected to have a VTE. The plasma levels of SF, D-dimer and FDP were significantly higher in patients with VTE than patients without VTE and those were significantly higher in patients without VTE than in healthy volunteers. In a receiver operating characteristic analysis for the diagnosis of VTE, the area under the curve was 0.950 for SF, 0.933 for FDP and 0.805 for D-dimer. The appropriate cut-off values for the diagnosis were as follows SF 5.9 microg/ml, FDP 2.1 microg/ml and D-dimer 4.8 microg/ml. To obtain a 100% negative predictive value for the diagnosis of VTE, the SF was less than 5.2 microg/ml, FDP was less than 1.3 microg/ml, and D-dimer was less than 0.5 microg/ml. Our findings suggest that the SF assay is useful for the diagnosis and exclusion of VTE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836793     DOI: 10.1007/s12185-008-0173-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  29 in total

1.  Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale.

Authors:  E Oger
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

2.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 3.  Clinical practice. The evaluation of suspected pulmonary embolism.

Authors:  Peter F Fedullo; Victor F Tapson
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

4.  Negative predictive value of D-dimer for diagnosis of venous thromboembolism.

Authors:  Hideki Nomura; Hideo Wada; Toshiro Mizuno; Naoyuki Katayama; Yasunori Abe; Maki Noda; Kaname Nakatani; Takeshi Matsumoto; Satoshi Ota; Norikazu Yamada; Akihiro Sudo; Atsumasa Uchida; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2008-02-19       Impact factor: 2.490

Review 5.  Are fibrin-related markers useful for the diagnosis of thrombosis?

Authors:  Hideo Wada; Nobuo Sakuragawa
Journal:  Semin Thromb Hemost       Date:  2008-02       Impact factor: 4.180

6.  Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.

Authors:  H Wada; N Sakuragawa; H Shiku
Journal:  Semin Thromb Hemost       Date:  1998       Impact factor: 4.180

7.  On soluble fibrinogen-fibrin complexes.

Authors:  H Graeff; R Hafter; R von Hugo
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

Review 8.  Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes.

Authors:  Roy F M van der Putten; Jan F C Glatz; Wim Th Hermens
Journal:  Clin Chim Acta       Date:  2006-05-11       Impact factor: 3.786

9.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis.

Authors:  Philip S Wells; David R Anderson; Marc Rodger; Melissa Forgie; Clive Kearon; Jonathan Dreyer; George Kovacs; Michael Mitchell; Bernard Lewandowski; Michael J Kovacs
Journal:  N Engl J Med       Date:  2003-09-25       Impact factor: 91.245

10.  Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura.

Authors:  H Wada; T Kaneko; M Ohiwa; M Tanigawa; T Hayashi; S Tamaki; N Minami; K Deguchi; K Suzuki; T Nakano
Journal:  Am J Hematol       Date:  1993-10       Impact factor: 10.047

View more
  8 in total

1.  Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.

Authors:  Kakunoshin Yoshida; Hideo Wada; Masahiro Hasegawa; Hiroki Wakabayashi; Takeshi Matsumoto; Yuji Shimokariya; Katsura Noma; Norikazu Yamada; Atsumasa Uchida; Tsutomu Nobori; Akihiro Sudo
Journal:  Int J Hematol       Date:  2012-01-21       Impact factor: 2.490

2.  Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery.

Authors:  Akihiro Sudo; Hideo Wada; Tsutomu Nobori; Norikazu Yamada; Masaaki Ito; Rui Niimi; Masahiro Hasegawa; Koji Suzuki; Atsumasa Uchida
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

3.  Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.

Authors:  Kakunoshin Yoshida; Hideo Wada; Masahiro Hasegawa; Hiroki Wakabayashi; Honami Ando; Seika Oshima; Takeshi Matsumoto; Yuji Shimokariya; Katsura Noma; Norikazu Yamada; Atsumasa Uchida; Tsutomu Nobori; Akihiro Sudo
Journal:  Int J Hematol       Date:  2011-09-22       Impact factor: 2.490

4.  Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.

Authors:  Takumi Aota; Katsuki Naitoh; Hideo Wada; Yoshiki Yamashita; Noriki Miyamoto; Masahiro Hasegawa; Hiroki Wakabayashi; Kakunoshin Yoshida; Kunihiro Asanuma; Takeshi Matsumoto; Kohshi Ohishi; Yuji Shimokariya; Norikazu Yamada; Masakatsu Nishikawa; Naoyuki Katayama; Atsumasa Uchida; Akihiro Sudo
Journal:  Int J Hematol       Date:  2014-09-25       Impact factor: 2.490

5.  Changes in soluble fibrin levels during the perioperative period of gynecologic cancer surgery.

Authors:  Junichi Kodama; Noriko Seki; Chikako Fukushima; Tomoyuki Kusumoto; Keiichiro Nakamura; Atsushi Hongo; Yuji Hiramatsu
Journal:  Oncol Lett       Date:  2012-08-31       Impact factor: 2.967

6.  Soluble fibrin is a useful marker for predicting extracorporeal membrane oxygenation circuit exchange because of circuit clots.

Authors:  Kota Hoshino; Kentaro Muranishi; Yasumasa Kawano; Hiroki Hatomoto; Shintaro Yamasaki; Yoshihiko Nakamura; Hiroyasu Ishikura
Journal:  J Artif Organs       Date:  2018-01-30       Impact factor: 1.731

7.  The role of soluble fibrin during anticoagulant therapy: a case report.

Authors:  Tohru Kawakami; Nobukiyo Tanaka; Hiroki Ishihara; Hiroyoshi Ohno
Journal:  Thromb J       Date:  2015-07-06

8.  The Usefulness of the Combination of D-Dimer and Soluble Fibrin Monomer Complex for Diagnosis of Venous Thromboembolism in Psychiatric Practice: A Prospective Study.

Authors:  Masahiro Takeshima; Hiroyasu Ishikawa; Masaya Ogasawara; Munehiro Komatsu; Dai Fujiwara; Yu Itoh; Yuki Wada; Yuki Omori; Hidenobu Ohta; Kazuo Mishima
Journal:  Vasc Health Risk Manag       Date:  2021-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.